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Reconstituted proteoliposomes containing Neuro- 
spot-a plasma membrane H’-ATPase molecules ori- 
ented predominantly with their cytoplasmic portion 
facing outward have been used to determine the loca- 
tion of the NH2 and COOH termini of the H+-ATPase 
relative to the lipid bilayer. Treatment of the proteo- 
liposomes with trypsin in the presence of the H+-ATP- 
ase ligands Mg’+, ATP, and vanadate produces approx- 
imately 97-, 95-, and 88-kDa truncated forms of the 
H+-ATPase similar to those already known to result 
from cleavage at Lys’*, Lys3’, and Arg73 at the NH2- 
terminal end of the molecule. These results establish 
that the NHz-terminal end of the H+-ATPase polypep- 
tide chain is located on the cytoplasmic side of the 
membrane. Treatment of the same proteoliposome 
preparation with trypsin in the absence of ligands re- 
leases approximately 50 water-soluble peptides from 
the proteoliposomes. Separation of the released pep- 
tides by high performance liquid chromatography and 
spectral analysis of the purified peptides identified 
only a few peptides with the properties expected of a 
COOH-terminal, tryptic undecapeptide with the se- 
quence SLEDFVVSLQR, and NH&erminal amino acid 
sequence analysis identified this peptide among the 
possible candidates. Quantitative considerations indi- 
cate that this peptide must have come from H+-ATPase 
molecules oriented with their cytoplasmic portion fac- 
ing outward, and could not have originated from a 
minor population of H’-ATPase molecules of reverse 
orientation. These results directly establish that the 
COOH-terminal end of the H+-ATPase is also located 
on the cytoplasmic side of the membrane. These find- 
ings are important for elucidating the topography of 
the membrane-bound H+-ATPase and are possibly rel- 
evant to the topography of other aspartyl-phosphoryl- 
enzyme intermediate ATPases as well. 
The long-term goal of this laboratory is to elucidate the 
molecular mechanism by which the plasma membrane H+- 
ATPase of Neurosporu crassa transduces the chemical energy 
of ATP hydrolysis into a transmembrane electrochemical 
proton gradient. Of critical importance in achieving this goal 
is an understanding of the molecular structure of the H+- 
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ATPase and its topography relative to the membrane in which 
it is embedded. Previous investigations of the topography of 
the H+-ATPase have been for the most part limited to inter- 
pretations of hydropathy profiles generated from analyses of 
the gene sequence. However, recent studies in this laboratory 
have provided methodology for preparing reconstituted H’- 
ATPase proteoliposomes in which the enzyme molecules are 
oriented predominantly with their cytoplasmic side facing 
outward (l), and methodology that allows for direct analyses 
of the protein chemistry of the H+-ATPase (2). The combi- 
nation of a well-defined, membrane-bound H’-ATPase prep- 
aration and methodology that allows for detailed analysis of 
the protein chemistry of the H+-ATPase provides the essential 
ingredients for rigorous physical and chemical investigations 
of the topography of the H+-ATPase. In the study described 
here, we present an improved procedure for preparing the 
reconstituted H+-ATPase proteoliposomes in which the bulk 
of the protein-free liposomes and any unreconstituted H’- 
ATPase molecules are removed and the proteoliposomes are 
concentrated, greatly simplifying subsequent analyses. We 
then initiate our investigation of the H+-ATPase topography 
by establishing the location of the NH2- and COOH-terminal 
ends of the H’-ATPase relative to the lipid bilayer in these 
proteoliposomes. The establishment of the location of the 
ends of the H’-ATPase polypeptide relative to the bilayer 
imposes simple but important constraints on subsequent top- 
ographic models of the enzyme, including whether there are 
an even or odd number of transmembrane segments in the 
H+-ATPase, and, as a model of the intramembranous portion 
of the enzyme is developed (3), the direction in which each of 
the membrane-spanning segments must traverse the mem- 
brane. 
EXPERIMENTAL PROCEDURES 
Purificution and Reconstitution of the H’-ATPast--The plasma 
membrane H+-ATPase of Neurospora crassa was purified as described 
previously (4, 5). The H+-ATPase was reconstituted into asolectin 
liposomes using a modification of the methods of Scarborough and 
Addison (1) and Goormaghtigh et al. (6). Briefly, 2 g of asolectin, 
purified by the procedure of Kagawa and Racker (7) and dissolved in 
chloroform, was placed in a 50-ml glass culture tube and the solvent 
removed under a stream of Nz followed by overnight storage under 
vacuum. Eighteen ml of buffer A (10 mM MES containing 50 mM 
potassium acetate, pH adjusted to 6.8 with KOH), and 2 ml of 0.1 M 
EDTA, pH adjusted to 6.8 with KOH, were then added to the dried 
asolectin. The tube was then flushed with N2, capped, and the mixture 
sonicated in a bath-type sonicator (Laboratory Supplies, Co., Inc., 
Hicksville, NY) until transparent (approximately 3 h). The liposome 
suspension was then diluted with 18 ml of buffer A and 2 ml of 0.1 M 
1 The abbreviations used are: MES, 2-(N-morpholino)ethane- 
sulfonic acid; HPLC, high performance liquid chromatography; 
PAGE, polyacrylamide gel electrophoresis; SLED. . ., tryptic peptide 
with the sequence SLEDFVVSLQR; SDS, sodium dodecyl sulfate. 
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EDTA, pH adjusted to 6.8 with KOH, centrifuged at 10,000 X g for 
20 min at 20 “C, and the supernatant fluid containing the liposomes 
decanted. Five ml of the purified H’-ATPase preparation (-2.6 mg 
of protein) was added to the liposome suspension, and the resulting 
mixture was inverted several times, frozen in a dry ice/methanol bath, 
and thawed at 30 “C. 
Purification and Concentration of the H+-ATPuse-bearing Lipo- 
somes-Five-ml aliquots of the proteoliposome preparation were OV- 
erlaid onto eight 35ml linear gradients of 24-40% (w/v) glycerol in 
buffer A. The gradient tubes were centrifuged at 60,000 rpm in a 
Beckman 70-Ti rotor (262,000 X g at raverage) for 18 h at 4 “C to 
separate the protein-free liposomes from those containing the recon- 
stituted H’-ATPase (6). After centrifugation, the gradients were 
fractionated into 2.1-ml aliquots and assayed for turbidity and activity 
in the presence and absence of nigericin (1). Fractions containing the 
peak activity from all of the gradients were pooled (total volume 
approximately 84 ml), diluted to 120 ml with buffer A, and 30-ml 
aliquots were underlaid with 10 ml of a solution containing 40% (w/ 
v) glycerol in buffer A. The step-gradients were then centrifuged at 
60,000 rpm in a Beckman 70-Ti rotor for 2 h at 4 ‘C to concentrate 
the proteoliposomes. The band of turbidity near the density interface 
in each tube was isolated, pooled (total volume typically 15 ml), and 
the proteoliposome suspension either used immediately or stored at 
-20 “C and used within 3 days. When stored at - 20°C the proteoli- 
posome suspension did not freeze, due to the high concentration of 
glycerol in the solution, and showed no loss of activity in the presence 
and absence of nigericin over the course of 1 week. 
Ttypsin Treatment of the H+-ATPase-bearing Liposomes in the 
Preskce and Absence ij Ligands and Analysis -of the Products by 
SDS-PAGE-The enriched, concentrated H+-ATPase proteolipo- 
some suspension was mixed with 0.05 volumes of a solution containing 
200 mM M&O& and 200 mM Na?ATP. DH adjusted to 6.8 with Tris. 
and 0.01 v&m& of 10 mM sodium orth’ovanadate, and preincubated 
at 30 “C. N-Tosyl-L-phenylalanine chloromethyl ketone-treated tryp- 
sin (1 mg/ml in buffer A, freshly prepared) was added to a final 
concentration of 1:lO (trypsin/H’-ATPase, w/w), and the solutions 
were incubated at 30 “C for O-160 min with occasional swirling. For 
all samples the sum of the preincubation time plus the time of 
incubation with trypsin equaled 160 min. At the end of the incubation, 
the digests were mixed with an equal volume of acidic disaggregation 
buffer (50 mM Tris, 4% (w/v) SDS, and 50 mM Z-mercaptoethanol, 
pH adjusted to 2.1 with HZPO,) and immediately analyzed by SDS- 
PAGE (8) on an 11 X 14 X 0.15-cm gel containing 7.5% polyacryl- 
amide in the resolving gel and 5% polyacrylamide in the stacking gel. 
Control samples containing no trypsin, or trypsin and no ligands 
were also processed and analyzed in the same way. The gels were 
stained with silver (9) and the staining intensities of the bands 
auantitated usine a Bio-Rad model 620 densitometer and Bio-Rad 
iD Analyst software. 
Trypsin Treatment of the H+-ATPase-bearing Liposomes and Sep- 
aration and Analysis of the Peptides Released-Fifteen ml of the 
enriched, concentrated ‘H+-ATPase proteoliposome suspension (ap- 
proximately I.5 mg of protein) was brought to 1% (w/v) ammonium 
bicarbonate, mixed with a N-tosyl-L-phenylalanine chloromethyl ke- 
tone-treated trypsin solution (1 mg/ml in buffer A, freshly prepared) 
to a final concentration of 1:lO (trypsin/H+-ATPase, w/w), and the 
mixture incubated at 37 “C for 7 h with occasional swirling. Following 
the incubation, the digest was loaded onto a 2.5 x 32-cm column of 
Senharose CLGB eauilibrated with buffer A, eluted with the same 
buffer at a flow rate-of approximately 20 ml/h, and 20-min fractions 
collected. The fractions containing the tryptic peptides released from 
the proteoliposomes (i.e. non-turbid, post-void volume fractions that 
absorbed light at 280 nm) were collected, pooled, and lyophilized 
overnight. Aliquots of the resulting sample, containing the released 
peptides in approximately 80% (w/v) glycerol, were filtered through 
0.45-pm nylon-66 filters (Rainin), and subjected to HPLC analysis. 
HPLC analyses were performed using a Waters HPLC instrument 
equipped with model 440 and 441 UV detectors and interfaced with 
a NEC APC IV computer and Waters Baseline 810 Chromatography 
Workstation software to control the pumps and collect and analyze 
the data. Peptides were resolved using a Bio-Rad RP-318 reversed- 
phase HPLC column (4.6 x 250 mm) eluted with a gradient of l- 
100% acetonitrile in Hz0 containing 0.1% trifluoroacetic acid as 
described previously (2). Eluate fractions containing peptides with 
the appropriate 214 and 280 nm signals to be candidates for the 
expected COOH-terminal trvptic peptide were collected, and the 
NH*-terminal sequences of two of these were determined (see “Re- 
sults and Discussion”). After this initial screening, the location and 
identity of the COOH-terminal peptide in the HPLC profile was 
verified by rechromatographing the appropriate eluate fraction and 
subjecting the repurified peptide to NHp-terminal sequence analysis 
as described under “Results and Discussion.” 
Peptide Amino Acid Composition and Sequence Analysis-Frac- 
tions containing the peptides purified by HPLC were sealed in glass 
ampoules and sent to the UCLA Microsequencing Center for amino 
acid composition and NH*-terminal sequence analysis. Amino acid 
compositions of the peptides were determined using a Waters Picotag 
system after acid hydrolysis (6 N HCl, 110 “C, 18 h, in uacuo under 
Na). Samples for sequence analysis were dried down on Polybrene- 
treated, Applied Biosystems GF/C glass fiber filters (10) and analyzed 
on an Applied Biosystems 475A sequencing system. 
Other Methods-The amount of protein in proteoliposome suspen- 
sions was determined by the method of Lowry et al. (11) as modified 
by Bensadoun and Weinstein (12), using bovine serum albumin as 
the standard. Suspensions containing an equal amount of asolectin 
liposomes, both with and without bovine serum albumin added, were 
used to determine the appropriate background values. The relative 
amount of phospholipid in proteoliposome suspensions was estimated 
by measuring the turbidity at 500 nm in a l-cm pathlength optical 
cell. The actual amount of phospholipid in the suspensions was 
determined by the method of Bartlett (13). 
Materials-The sources of most of the materials used have been 
described previously (1, 2, 4). 
RESULTS AND DISCUSSION 
We have previously shown that approximately 90% of the 
H+-ATPase molecules in H+-ATPase proteoliposomes pre- 
pared by our original freeze-thaw procedure are functional 
and oriented with their cytoplasmic surface on the outside of 
the liposome (1). This is a potentially useful preparation with 
which to investigate certain aspects of the H+-ATPase topog- 
raphy. However, significant drawbacks of this reconstituted 
preparation for studies of the H+-ATPase topography are the 
presence of a large excess of H+-ATPase-free liposomes, which 
interferes with subsequent protein chemical analyses, the 
possible presence of unreconstituted H+-ATPase molecules, 
which could lead to topographical artifacts, and a rather low 
concentration of protein, which also makes subsequent anal- 
yses difficult. As we have shown in a recent communication 
(6), the density of H’-ATPase-containing liposomes is greater 
than that of H+-ATPase-free liposomes, owing to the greater 
density of the protein. It is therefore possible to separate the 
H+-ATPase-containing and H+-ATPase-free liposomes on a 
glycerol density gradient. Fig. 1 shows the results of glycerol 
gradient purification of the freeze-thaw reconstituted H+- 
ATPase proteoliposome preparation. The five fractions with 
the greatest H’-ATPase activity contain approximately one- 
third of the phospholipid, as measured by phospholipid phos- 
phorus assay (data not shown), and two-thirds of the ATPase 
activity loaded onto the gradient, which constitutes a signifi- 
cant enrichment of the H’-ATPase-containing liposomes. 
The gradient-enrichment step offers the added advantage that 
any unreconstituted H’-ATPase molecules, which are hex- 
amers of the lOO-kDa monomers as isolated (14), are sedi- 
mented to the bottom of the gradient and thus removed (data 
not shown). 
Fig. 1 also shows that the H’-ATPase activity in the en- 
riched liposome pool is stimulated greater than 2-fold by the 
addition of nigericin in the presence of K+. As we have 
developed in greater detail elsewhere (l), this degree of stim- 
ulation by nigericin indicates that the majority of the func- 
tional, cytoplasmic-side-out H+-ATPase molecules in the re- 
constituted, gradient-enriched proteoliposomes translocate 
protons into a sealed space, which is an important consider- 
ation for any topography study. 
Finally, concentration of the enriched proteoliposome prep- 
aration by centrifugation on a glycerol step-gradient, as de- 
scribed under “Experimental Procedures,” results in a prep- 
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FIG. 1. Separation of H+-ATPase-containing liposomes 
from H+-ATPase-free liposomes by glycerol gradient centrif- 
ugation. The H’-ATPase was reconstituted into sonicated asolectin 
liposomes and the preparation subjected to glycerol density gradient 
centrifugation as described under “Experimental Procedures.” The 
gradients were fractionated and the fractions assayed for turbidity 
and H+-ATPase activity in the presence and absence of nigericin. 
aration containing approximately 100 lg of protein/ml and 
50 mg of phospholipid/ml (data not shown). The specific 
activity of the H’-ATPase in a typical preparation is about 
10 pmol of P,/min/mg of protein in the absence of nigericin 
and about 22 Fmol of P,/min/mg of protein in the presence 
of nigericin, comparable to that of proteoliposome prepara- 
tions before the gradient enrichment and concentration steps 
(1,6), indicating that the gradient enrichment and concentra- 
tion steps do not significantly affect the functionality of the 
reconstituted H+-ATPase molecules or the liposomes them- 
selves. These specific activities also indicate that the func- 
tionality and orientation of the H+-ATPase molecules in the 
final liposome preparation are similar to that previously es- 
tablished (1). 
Additional support for these conclusions is presented in 
Fig. 2. As described in detail before (l), SDS-PAGE analysis 
of H’-ATPase-bearing proteoliposomes in the presence and 
absence of H+-ATPase ligands can be used to estimate the 
percent of H’-ATPase molecules in the preparation that are 
functional and oriented with their cytoplasmic side facing 
outward. Membrane-embedded H+-ATPase molecules ori- 
ented with their cytoplasmic side out are readily degraded by 
trypsin with the production of relatively small peptides. Ad- 
ditionally, recent data (not shown) indicates that H+-ATPase 
molecules with the reverse orientation are extremely resistant 
to any degradation by trypsin. Fig. 2A shows a time course of 
tryptic digestion of the H’-ATPase proteoliposome prepara- 
tion described in this report in the absence of H+-ATPase 
ligands. Densitometric analyses of these gel lanes indicated 
that approximately 85-90% of the H’-ATPase molecules in 
the proteoliposome preparation were reduced to small pep- 
tides upon exposure to trypsin, which means that 85-90% of 
the H’-ATPase molecules in the preparation are oriented 
with their cytoplasmic side facing out. Conversely, lo-15% of 
the H’-ATPase molecules in the proteoliposome preparation 
were resistant to tryptic digestion, presumably representing a 
cytoplasmic-side-in population of H’-ATPase molecules. 
Tryptic digestion of H’-ATPase molecules in the presence 
of the active site ligands Mg*+ plus vanadate or Mg*+ plus 
ATP plus vanadate results in truncation of the H’-ATPase 
molecule to -97-, 95-, and 88-kDa forms, with relatively slow 
degradation of these forms to smaller peptide fragments (15, 
16). And, as elaborated in detail earlier (l), this ligand- 
protection of the H’-ATPase against tryptic digestion is a 
measure of the functionality of the H’-ATPase molecules in 
the reconstituted proteoliposome preparation. Fig. 2B shows 
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FIG. 2. SDS-PAGE analysis of the H+-ATPase proteolipo- 
somes following tryptic digestion in the absence and presence 
of Mg 2+, ATP, and vanadate. Samples of the H’-ATPase proteo- 
liposomes containing approximately 3 pg of protein were subjected to 
tryptic digestion and the products analyzed by SDS-PAGE as de- 
scribed under “Experimental Procedures.” Panel A, tryptic digestion 
of the H+-ATPase proteoliposomes in the absence of ligands for 0, 
10, 40, 80, and 160 min. Panel B, tryptic digestion of the H’-ATPase 
proteoliposomes in the presence of Mg*‘, ATP, and vanadate for 0, 
10, 40, 80, and 160 min. The numbers to the left of the gel lanes 
indicate the positions and molecular masses in kDa of ,B-galactosidase 
(M, 116,250), phosphorylase b (M, 97,400), and bovine serum albumin 
(M, 66,200), in the gel. Only the region of the gel containing the 
peptides of interest is shown. Very little staining material was seen 
elsewhere in the sample lanes. 
the time course of tryptic digestion of the H’-ATPase proteo- 
liposome preparation described in this report in the presence 
of Mg’+, ATP, and vanadate. Densitometric analyses of these 
gel lanes showed that approximately 80% of the mass of the 
H’-ATPase was protected as the 97-, 95-, and 88-kDa forms 
until the later stages of the tryptic digestion, indicating that 
about 80% of the H’-ATPase molecules in the preparation, 
virtually all of the cytoplasmic-side-out molecules, are respon- 
sive to the H’-ATPase ligands and are therefore functional. 
The combined results of all of these analyses thus demon- 
strate that 85-90% of the H’-ATPase molecules in the pro- 
teoliposome preparation used in these studies are oriented 
with their cytoplasmic surface facing outward and that the 
great majority of these molecules are functional. 
The improved reconstituted H’-ATPase preparation is 
therefore well-defined with respect to the H’-ATPase orien- 
tation and functionality, enriched in the H+-ATPase-contain- 
ing liposomes, essentially free of unreconstituted H’-ATPase 
molecules, and adequately concentrated with respect to H’- 
ATPase protein, and is thus a very useful system for studies 
of the H’-ATPase topography. 
The results shown in Fig. 2 also establish the topographic 
location of the amino-terminal end of the H+-ATPase mole- 
cule. A recent study by Mandala and Slayman (16) demon- 
strated that conversion of the lOO-kDa native polypeptide to 
the -97-, 95-, and 88-kDa forms by trypsin is due to cleavage 
at LYS*~, Lys”‘, and Arg7”, respectively. Thus, the generation 
of these truncated forms of the H’-ATPase is a measure of 
tryptic cleavage at the NH2 terminus of the molecule. There- 
fore, because the great majority of the H’-ATPase molecules 
in the proteoliposomes used in these studies were oriented 
with their cytoplasmic side out, the fact that most of the H+- 
ATPase molecules in the preparation are converted to -97-, 
95-, and 88-kDa truncated forms by trypsin in the presence 
of Mg*+, ATP, and vanadate, demonstrates that the NH, 
terminus is located on the cytoplasmic side of the membrane. 
Our strategy for determining the presence or absence of the 
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COOH terminus of the H’-ATPase in the cytoplasmic portion 
of the enzyme molecule was to analyze the peptides released 
from the above-described H’-ATPase proteoliposomes after 
trypsin treatment in the hopes of identifying a fragment from 
the COOH terminus of the enzyme, Two factors greatly 
simplified the search for such a peptide among the numerous 
tryptic cleavage products released from the proteoliposomes. 
First, hydropathy analyses of the amino acid sequence of the 
H+-ATPase (2, 17, 18) and investigations of the fragments of 
the H’-ATPase remaining associated with the liposomes after 
trypsin treatment (3) indicate that there are approximately 
40 residues on the COOH-terminal side of the last membrane- 
spanning segment. This COOH-terminal portion of the en- 
zyme contains six potential tryptic cleavage sites, with the 
largest tryptic fragment expected to contain between 11 and 
29 residues and no tyrosine or tryptophan (Fig. 3). Thus, if 
one or more peptides are released from the COOH terminus 
of the H+-ATPase by trypsin treatment of the proteolipo- 
somes, the largest of these peptides should have a substantial 
absorbance at 214 nm and relatively little absorbance at 280 
nm. The second factor that simplified the search is the ana- 
lytical capability of currently available HPLC data acquisition 
and analysis software. With such software, it is possible to 
definitively examine the absorbance characteristics of each 
peak in an HPLC eluate and thus pinpoint peptides of a 
specific type for further purification and analysis. 
Fig. 4 shows the results of HPLC analysis of the peptides 
released from the H+-ATPase proteoliposomes by tryptic 
digestion. In this experiment, the proteoliposomes were 
treated with trypsin and subjected to gel filtration chroma- 
tography to separate the released peptides from the liposomes. 
The eluate fractions containing the released peptides were 
pooled, and the peptides concentrated by lyophilization and 
subjected to HPLC analysis. Out of a total of approximately 
50 peaks in the profile, four peaks, indicated by the arrows 
with the numbers, had relatively high A214 ,,,,, and distinctively 
high ratios of AZ,, nm to A 280 nm, and were thus chosen as most 
likely to be the COOH-terminal peptide of interest. NH*- 
terminal sequence analysis of the fraction containing peak 
number 1, eluting at about 108 min, was determined first and 
yielded the sequence TVEEDHPIPEEVDQAYK, identifying 
the major peptide in this sample as residues 483-499 of the 
H’-ATPase by reference to the gene sequence (17, 18). Se- 
quence analysis of the fraction containing peak number 3, 
eluting at about 154 min, indicated the presence of the COOH- 
terminal peptide SLEDFVVSLQR, which begins at residue 
901 and ends at residue 911 of the H+-ATPase sequence. 
Rechromatography of this sample on the same gradient re- 
vealed the presence of peptides eluting at 152 and 154 min. 
Therefore, the peptide in the peak eluting at 154 min in the 
second chromatogram was sequenced again, establishing that 
this peak represents the 11 residue COOH-terminal peptide 
with the sequence SLEDFVVSLQR. 
Whereas about 85-90% of the H+-ATPase molecules in the 
reconstituted proteoliposomes are oriented with their cyto- 
plasmic surface facing outward, as indicated by tryptic cleav- 
age experiments (Ref. 1, and Fig. 2), about lo-15% of the H+- 




FIG. 3. Amino acid sequence of the COOH-terminal end of 
the Neurospora plasma membrane H+-ATPase and possible 
tryptic cleavage sites. Shown are the last 36 residues of the COOH 
terminus of the H’-ATPase, deduced from the gene sequence (17, 
18). The spaces indicate the possible tryptic cleavage sites, and the 
900 indicates residue 900. 
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FIG. 4. HPLC analysis of the peptides released from the H+- 
ATPase proteoliposomes by tryptic digestion. Tryptic peptides 
released from the H’-ATPase proteoliposomes were prepared as 
described under “Experimental Procedures.” A sample (880 ~1) con- 
taining the peptides released from 200 fig of reconstituted H+-ATPase 
protein was subjected to HPLC analysis. The numbered arrows indi- 
cate the peptide peaks that were initially selected as possible candi- 
dates for the COOH-terminal peptide as described under “Results 
and Discussion.” Insets, enlargements of the boxed portions of the 
HPLC elution profiles. The peak representing the SLED.. peptide 
is identified by the downward pointing arrow. Panel A shows the 
AZ14 “,,, profile, and panel B shows AgSnrn profile. 
ATPase molecules in the preparation are resistant to trypsin, 
presumably indicating a reverse orientation of these mole- 
cules. In order to ensure that the SLED.. . peptide was 
released from the predominant population of cytoplasmic- 
side-out H+-ATPase molecules, rather than from the minor 
population of H’-ATPase molecules with the other orienta- 
tion, it was important to quantitate the recovery of this 
peptide relative to the amount of H’-ATPase used in the 
experiment. To do this, the hydrophilic peptides generated 
from limit tryptic hydrolysis of the purified H+-ATPase were 
used as a calibration standard for the HPLC analyses. Pre- 
vious analyses of this peptide mixture indicated that, subse- 
quent to HPLC analysis, approximately 80% of the mass of 
the peptides is recovered relative to the amount expected from 
the starting mass of purified H’-ATPase (2). Thus, the areas 
of the peaks in the 214 nm profile from HPLC analysis of the 
calibration standard reflect on average approximately 80% of 
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the mass of each peptide expected from tryptic cleavage and 
HPLC analysis of a given starting amount of the purified H’- 
ATPase, and the areas of comparable peaks in the HPLC 
analysis of the peptides released by trypsin treatment of the 
reconstituted H’-ATPase (Fig. 4) can be used to estimate the 
mass, and therefore the recovery, of individual peptides rela- 
tive to the starting mass of the enzyme. Based on this cali- 
bration standard, measurements of the area of the peak at 
154 min from five preparations of the H’-ATPase proteoli- 
posomes indicated that 45 + 5% of this peptide was recovered 
relative to the amount expected if complete tryptic cleavage 
of all of the cytoplasmic-side-out H+-ATPase molecules in 
the proteoliposomes, and complete recovery of the peptides 
from the various sample processing steps, had occurred. Cor- 
recting this recovery value for the -20% losses that occur 
with the standard peptides from the purified H’-ATPase, the 
estimated amount of the SLED.. . peptide released from the 
proteoliposomes would be substantially higher. And, this is a 
minimum estimate since the manipulations involved in puri- 
fying peptides released from the proteoliposomes are much 
more extensive than those involved in the purification of the 
standard peptides, significantly increasing the probability of 
additional losses of the proteoliposome-derived peptides. This 
recovery estimate thus precludes the possibility that the 
SLED. . . peptide was derived from H+-ATPase molecules 
with their cytoplasmic side facing inward, as peptides gener- 
ated from these molecules could result in no greater than 15% 
recovery of peptide mass upon complete hydrolysis and recov- 
ery. These data thus provide direct physical evidence that the 
SLED.. . peptide, and thus the COOH-terminal end of the 
H’-ATPase molecule, must reside in the cytoplasmic domain 
of the functional H’-ATPase molecule. 
Prior to this study, little evidence was available regarding 
the location of the NH,- and COOH-terminal ends of the 
Neurosporu H+-ATPase relative to the membrane bilayer. 
The results presented here provide conclusive evidence that 
both ends of the H’-ATPase polypeptide are present on the 
cytoplasmic side of the membrane. This finding is of funda- 
mental importance for developing a topographic model of the 
H’-ATPase as it exists in the membrane in that the location 
of the ends of the polypeptide on the same side of the mem- 
brane directly implies that the H+-ATPase polypeptide must 
contain an even number of membrane-spanning segments. 
Furthermore, as a model for the membrane-embedded regions 
of the H+-ATPase molecule is evolved (3), these data will 
have important implications regarding the direction in which 
the membrane-spanning segments of the polypeptide pass 
through the lipid bilayer. 
Evidence regarding the location of the terminal ends of 
other ATPases in the aspartyl-phosphoryl-enzyme interme- 
diate family is limited but generally consistent with the find- 
ings reported here. Davis and Hammes’ (19) examination of 
the reconstituted yeast plasma membrane H+-ATPase indi- 
cates the presence of an elastase cleavage site on the cyto- 
plasmic side of the membrane approximately 45 residues away 
from the COOH terminus, which is in reasonable agreement 
with the cytoplasmic location of residues 901-911 of the 
Neurosporu H’-ATPase reported here. However, these inves- 
tigators concluded that the COOH terminus of the yeast H+- 
ATPase is on the exocytoplasmic side of the membrane due 
to the resistance of the COOH terminus to degradation by 
carboxypeptidase Y in the absence of detergents. As an alter- 
native explanation of these findings, Davis and Hammes (19) 
suggested that the COOH terminus might be present on the 
cytoplasmic side but inaccessible to carboxypeptidase Y. In 
view of the results presented here, we favor this latter expla- 
nation because, at least for the Neurosporu enzyme, it is 
unlikely that the last nine relatively hydrophilic residues are 
buried in the bilayer. Otherwise, it must be concluded that 
these two enzymes, which have similar function and 75% 
sequence identity, have different topographies. Regarding the 
topography of other ATPases in this family, N-ethylmaleim- 
ide labeling of a cysteine residue near the NH, terminus of 
the Ca’+-ATPase in a sarcoplasmic reticulum vesicle prepa- 
ration (ZO), has been taken to indicate that the NH2 terminus 
of this enzyme is on the cytoplasmic side of the membrane. 
And, the localization of the calmodulin-binding region of the 
plasma membrane Ca”-ATPase suggests that the COOH 
terminus of this enzyme is on the cytoplasmic side of the 
membrane (21,22). Additionally, analyses of tryptic peptides 
released from isolated plasma membrane vesicles have been 
offered as evidence that the NH2 terminus of the a-subunit 
of the Na+/K+-ATPase is located on the cytoplasmic side of 
the membrane (23, 24). Interestingly, a recent monoclonal 
antibody binding study by Ovchinnikov et al. (25) concludes 
that the COOH terminus of the a-subunit of the Na’/K+- 
ATPase is on the exocytoplasmic side of the membrane. Thus, 
the Na’/K+-ATPase topography may be significantly differ- 
ent from that of the Neurospora plasma membrane H+-ATP- 
ase and the plasma membrane Ca”-ATPase. The apparent 
difference could somewhow be related to the presence of the 
essential P-subunit of the Na’/K+-ATPase, which appears to 
interact with membrane-spanning segments in the COOH- 
terminal portion of the o-subunit (26). Alternatively, an in- 
herent problem with antibody binding as a method for topo- 
graphical analysis of integral membrane protein structure is 
that of cross-reactivity of antibodies with regions of the 
molecule other than those they were designed for. Cross- 
reactivity of monoclonal antibodies for segments of the ace- 
tylcholine receptor has been documented and appears to be 
responsible for the incongruous topographic models of this 
molecule that have been generated from this experimental 
approach (27-29). This would suggest that the results of 
antibody binding studies of the Na’/K’-ATPase should prob- 
ably be confirmed by other analytical methods. 
In conclusion, in this article we have described an improved 
preparation of reconstituted proteoliposomes containing the 
Neurospora plasma membrane H’-ATPase and have used 
these proteoliposomes to demonstrate that the NH*- and 
COOH-terminal ends of the membrane-bound form of the 
H’-ATPase are located on the cytoplasmic side of the mole- 
cule. These findings are an important first step toward defin- 
ing the topography of this H+-ATPase and provide valuable 
constraints for interpreting the results of our investigations 
of its membrane-embedded regions (3), and for future studies 
of the extramembranous portions of this molecule. Addi- 
tionally, these findings may be relevant to the topography of 
other ATPases in the aspartyl-phosphoryl-enzyme interme- 
diate family. 
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